Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478690/
https://www.ncbi.nlm.nih.gov/pubmed/36119642
http://dx.doi.org/10.1177/17588359221127078
_version_ 1784790628703404032
collection PubMed
description
format Online
Article
Text
id pubmed-9478690
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-94786902022-09-17 Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%” Ther Adv Med Oncol Corrigendum SAGE Publications 2022-09-13 /pmc/articles/PMC9478690/ /pubmed/36119642 http://dx.doi.org/10.1177/17588359221127078 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Corrigendum
Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”
title Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”
title_full Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”
title_fullStr Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”
title_full_unstemmed Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”
title_short Corrigendum to “Network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with PD-L1 expression ⩾50%”
title_sort corrigendum to “network meta-analysis of immune-oncology monotherapy as first-line treatment for advanced non-small-cell lung cancer in patients with pd-l1 expression ⩾50%”
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478690/
https://www.ncbi.nlm.nih.gov/pubmed/36119642
http://dx.doi.org/10.1177/17588359221127078

Ejemplares similares